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           Toll-like receptors (TLRs) were fi  rst identifi  ed 
as receptors for microbial products that trigger 
innate immunity (  Beutler and Rietschel, 2003  ). 
All TLR receptors, with the exception of TLR3, 
use the adaptor protein MyD88 and are capable 
of activating NF-    B. TLR3 and TLR4 recep-
tors couple to the TIR domain–containing 
adapter-inducing IFN-     (TRIF), which trig-
gers type I IFN production. Naive mouse B 
cells express a variety of TLRs and can be poly-
clonally stimulated by either TLR4 or TLR9 
ligands to proliferate and diff  erentiate  into 
Ig-secreting cells. The role of TLRs in T cell–
dependent immune responses in mice is con-
troversial, as one study has shown a requirement 
for TLR activation, whereas others have shown 
that TLR signals only help to amplify the re-
sponses (  Pasare and Medzhitov, 2005  ;   Gavin 
et al., 2006  ;   Meyer-Bahlburg et al., 2007  ). The 
TLR repertoire of human B cells diff  ers some-
what from that of mice, as naive human B cells 
have low levels of TLR expression. However, 
B cell antigen receptor (BCR) stimulation in-
duces strong expression of TLR6, TLR7, 
TLR9, and TLR10 (  Peng, 2005  ). The prolifer-
ation and diff  erentiation of naive human B cells 
to Ig-secreting cells may require exposure to 
TLR ligands in addition to a BCR signal and a 
cognate interaction with helper T cells (  Ruprecht 
and Lanzavecchia, 2006  ). Like naive mouse 
B cells, human memory B cells constitutively 
express several TLRs, although not TLR4, 
and can respond directly to TLR stimulation 
(  Bernasconi et al., 2003  ). The treatment of 
human peripheral blood B cells with TLR7 or 
TLR9 agonists induces increased cytokine and 
chemokine production as well as the secretion 
of IgG and IgM (  Hanten et al., 2008  ). 
  Inappropriate TLR signaling has been asso-
ciated with autoimmunity (  Krieg and Vollmer, 
2007  ). TLR4 up-regulation can break immuno-
logical tolerance and induce a lupus-like auto-
immune disease in mice (  Liu et al., 2006  ). In 
addition, TLR9 or TLR3 engagement has been 
shown to stimulate autoreactive B cells to se-
crete antibody (  Ding et al., 2006  ). Overexpres-
sion of B cell–activating factor of the tumor 
necrosis factor family (BAFF) promoted a 
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  B lymphocyte–intrinsic Toll-like receptor (TLR) signals amplify humoral immunity and can 
exacerbate autoimmune diseases. We identify a new mechanism by which TLR signals may 
contribute to autoimmunity and chronic infl  ammation. We show that TLR4 signaling en-
hances B lymphocyte traffi  cking into lymph nodes (LNs), induces B lymphocyte clustering 
and interactions within LN follicles, leads to sustained in vivo B cell proliferation, over-
comes the restriction that limits the access of nonantigen-activated B cells to germinal 
center dark zones, and enhances the generation of memory and plasma cells. Intravital 
microscopy and in vivo tracking studies of B cells transferred to recipient mice revealed 
that TLR4-activated, but not nonstimulated, B cells accumulated within the dark zones of 
preexisting germinal centers even when transferred with antigen-specifi  c B cells. The TLR4-
activated cells persist much better than nonstimulated cells, expanding both within the 
memory and plasma cell compartments. TLR-mediated activation of B cells may help to 
feed and stabilize the spontaneous and ectopic germinal centers that are so commonly 
found in autoimmune individuals and that accompany chronic infl  ammation. 
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  Figure 1.    Signaling through TLR4 enhances B cell chemokine responsiveness.   (A) Receptor expression. Splenic B cell was activated with LPS for 18 h 
or not activated. Stimulated B cell profi  les, nonactivated B cell profi  les, and isotype controls for indicated receptor are shown. A representative result is 
depicted from six performed experiments. (B) Chemotaxis assays. Stimulated and nonactivated B cell was subjected to 2 h of chemotaxis in response to 
CXCL12, CCL19, or CXCL13. The specifi  c migration is shown. Results are mean and SE of sextuplet samples from six experiments (*, P < 0.01 vs. nonacti-
vated B cell). (C) Chemotaxis to CXCL16, CXCL9, or CCL25. Results are mean and SE of sextuplet samples from six experiments. (D) Homing assay. Ten mil-
lion differentially labeled LPS-activated and nonactivated B cells were intravenously transferred to recipient mice (six experiments each with three pairs JEM VOL. 206, November 23, 2009 
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of mice; *, P < 0.01 vs. nonactivated B cell). 2 h after transfer, cells of the recipient mice were analyzed by fl  ow cytometry. Shown are the actual number 
of transferred B cells found in blood (/10 μl), spleen (× 10  3   cells), iLN (× 10  2   cells), and pLN (× 10  2   cells). (E) LN transit assay. 10 million differentially la-
beled LPS-treated B cells and nontreated B cells were intravenously transferred (six experiments each with three pairs of mice; *, P < 0.01 vs. nonactivated 
B cell). 100 μg/mouse of anti–L-selectin antibody was injected intravenously 2 h after transfer. Control mice were injected with PBS (white bars) and ana-
lyzed immediately. Cells were isolated from the indicated sites and analyzed by fl  ow cytometer at 12 h (shaded bars) and 24 h (black bars) after antibody 
injection. (F) Ratios. The ratios between 12 h of antibody, 24 h of antibody, and PBS-treated control groups are shown from the data in E. Error bars indi-
cate means ± SEM each with three pairs of mice in six experiments.      
 
lupus-like disease in mice, which was independent of T cells 
but required B cell–intrinsic signals through the TLR adapter 
MyD88 (  Groom et al., 2007  ). In addition, several studies 
have implicated dual BCR-TLR signaling in the pathogene-
sis of autoimmune diseases (  Lanzavecchia and Sallusto, 2007  ). 
For example, DNA-containing Ig complexes activated auto-
reactive B cells to produce antibodies against self-IgG 
(  Leadbetter et al., 2002  ) and, in MRL  lpr/lpr   mice, B cells that 
recognized self-IgG  2a   depended on endogenous TLR ligands 
to trigger their expansion and diff  erentiation to Ig secretion 
(  William et al., 2002  ;   Herlands et al., 2008  ). 
  A hallmark of many autoimmune diseases is the formation 
of ectopic and excessive numbers of germinal centers (  Luzina 
et al., 2001  ;   Hsu et al., 2008  ). Germinal centers are a site where 
B lymphocytes undergo clonal expansion, class switch recom-
bination, antibody gene diversifi  cation, and affi   nity maturation 
(  Liu et al., 1989  ;   Jacob et al., 1991  ;   MacLennan, 1994  ). TLR 
signaling has also been linked to germinal center formation. 
Injection of the TLR4 ligand LPS into the foot pad of mice 
induced the formation of new LN follicles and germinal cen-
ters (  Horie and Hoshi, 1989  ). Immunization with DNP-LPS, 
which engages both DNP-specifi   c antigen receptors and 
TLR4, initially decreased cell proliferation within preexisting 
germinal centers, which was followed by increased germinal 
center cell proliferation (  Goodlad and Macartney, 1995  ). In 
addition, after murine gammaherpesvirus 68 infection, 
MyD88      /      B cells failed to become activated and to enter into 
germinal centers (  Gargano et al., 2008  ). 
  Despite the importance of TLR signaling in regulating 
human and mouse B cell function and its linkage to autoim-
munity, the impact of TLR signaling on the traffi   cking of 
human and mouse B cells has received little recent attention. 
One study examined the distribution in recipient mice of 
transferred radiolabeled B cells, stimulated in vitro with LPS 
or not, and concluded that LPS stimulation had little impact 
on B cell traffi   cking (  Freitas and de Sousa, 1976  ). Since that 
study, much has been learned about how B lymphocytes traf-
fi  c into and within lymphoid organs. Naive and memory 
B cells enter LNs from the circulation by crossing high endo-
thelial venules, whereas memory B cells can also enter via 
aff  erent lymphatics (  Cyster, 2005  ). Once within LNs, most 
B cells rapidly localize in the LN follicle. Intravital two-photon 
laser-scanning microscopy (TP-LSM) of mouse LNs has 
shown that follicular B cells move with an mean velocity of 
6 μm/min along the processes of follicular DCs (FDCs;   Miller 
et al., 2002  ;   Han et al., 2005  ;   Bajénoff   et al., 2006  ). CXCL13 
associated with the FDCs fuels B cell motility in the follicle. 
B lymphocytes from mice that possess B cells hyperrespon-
sive or hyporesponsive to chemokines move faster or slower, 
respectively, than do wild-type B cells (  Han et al., 2005  ). 
Follicular B cells that encounter their cognate antigen up-
regulate CCR7 expression and migrate to the B-T boundary 
to receive T cell help (  Reif et al., 2002  ;   Okada et al., 2005  ). 
This leads to B cell proliferation and diff  erentiation into ex-
trafollicular plasmablasts or to the seeding of germinal cen-
ters, which produce memory B cells and plasmablasts. 
  This study examines the consequences of TLR4 activa-
tion on mouse B cell chemokine responsiveness, lymphocyte 
traffi   cking, in vivo proliferation, and the behavior of the acti-
vated B cells within LNs. Direct visualization of the TLR4-
activated B cells within LN follicles of live mice using 
TP-LSM demonstrated B–B cell interactions and the recruit-
ment of the TLR4 ligand–exposed cells into the dark zones 
of germinal centers present in LNs. Many of the transferred 
TLR4-activated cells persist in mice and expand within the 
memory and plasma cell compartments. The implications of 
these observations are discussed. 
  RESULTS 
  TLR4 stimulation enhanced the B lymphocyte 
migratory program 
  We used fl  ow cytometry to examine the eff  ects of the TLR4 
ligand LPS on the levels of homing and chemokine receptors. 
B cells stimulated with LPS increased their expression of the 
chemokine receptors CCR7 and CXCR5 and, to a lesser 
extent, CXCR4. In addition, the expression of CXCR3, 
CXCR6, and CCR9 were induced. LPS stimulation also in-
creased the expression of the homing receptor L-selectin and 
proteins involved in cell adhesion, including CD11a and 
ICAM-1, although it did not alter CD49d. As expected, the 
activation marker GL-7 expression was enhanced by TLR4 
stimulation (  Fig. 1 A  ).   Similar results were obtained when 
we compared freshly isolated B cells versus TLR4 ligand–
stimulated B cells (  Fig. S1 A  ). The LPS-exposed B cells re-
sponded better to CXCL12 (receptor CXCR4), CCL19 
(receptor CCR7), and CXCL13 (receptor CXCR5) than did 
the unexposed B cells in chemotaxis assays (  Fig. 1 B  ). The 
magnitude of the diff  erence was greater for CXCL13 and 
CCL19 than for CXCL12. In addition, some of the LPS-
exposed B cells acquired responsiveness to CXCL16 (recep-
tor CXCR6), CXCL9 (receptor CXCR3), and CCL25 
(receptor CCR9;  Fig. 1 C ). These diff  erences existed whether 
we compared stimulated B cells to cultured B cells or to 
freshly isolated B cells (Fig. S1 B). Because of the importance 2644 TLR4-activated B cells in germinal centers   | Hwang et al. 
  Figure 2.    Comparison of TLR4 ligand–exposed or nonexposed B cells in the iLN by intravital TP-LSM.   (A) Imaging. Labeled LPS-activated and 
control B cells were transferred to recipient mice and the iLN was imaged various days after transfer. A maximum intensity projection (MIP) of a 33-μm 
image stack shows LPS-activated B cells (green) and nontreated B cells (red). Bars, 50 μm. (B) Zoomed images. An MIP 4× zoom is shown of days 1–3. The 
day-4 data were obtained using CFSE-labeled and transferred LPS-activated B cells. Arrows point to LN follicle edge. Bar, 12.5 μm. (C) Motility parameters. 
Each data point represents a single cell and green and red bars indicate mean values (*, P < 0.05; **, P < 0.01). (D) Tracks. Superimposed 20-min tracks of 
randomly selected cells of indicated types in the x, y plane setting the starting coordinates to the origin. Data are from the analysis of four recipient mice 
at the indicated times. The experiment was done three times with similar results.     JEM VOL. 206, November 23, 2009 
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  Tracking individual cells revealed that, on average, the 
TLR4 ligand–exposed B cells moved slightly faster than did 
the control B cells at 24 h; however, at 48 and 72 h after trans-
fer the diff  erence was negligible (  Fig. 2 C   and not depicted). It 
is of note that a small portion of the TLR4 ligand–exposed B 
cells (    5%) exhibited an extreme polarized morphology with 
a long thin uropod, often with a length of two or three cell 
bodies, rather like a kite with a tail. At each of the time points 
examined the stimulated B cells moved slightly straighter, with 
less speed variability, and with a greater mean displacement 
than the nonstimulated cells (  Fig. 2 C   and not depicted). The 
greater displacement is readily visualized by plotting an equal 
number of randomly selected individual tracks from the same 
origin (  Fig. 2 D  ). 
  Within the LN follicle, some of the TLR4 ligand–exposed 
B cells formed transient clusters of highly interactive cells. The 
clusters, which were often composed of fi  ve or more cells, 
persisted for as long as 10 min. Individual frames from the in-
travital imaging of transferred B cells present in the iLN of the 
recipient mouse are shown in   Fig. 3 A   and   Video 2  (green).   
Highlighted over the fi  rst 7 min is a cluster of fi  ve to seven B 
cells, which showed extensive cell–cell interactions (  Fig. 3 A  , 
top). After     8 min, the cluster disappeared and another clus-
ter of B cells appeared just above the previous cluster. Again 
composed of fi  ve to seven B cells, the cluster lasted for     8 min 
and then began to dissipate. An example of a B cell with a long 
uropod is shown in   Fig. 3 A   (22:30). Another set of previously 
stimulated B cells tracked over a 15-min period 48 h after 
transfer is shown in   Fig. 3 B  . To determine the number of in-
teractions and the duration of the interactions, we tracked the 
two populations 48 h after transfer. We found that, on aver-
age, the TLR4 ligand–exposed B cells had twice as many con-
tacts, which lasted 70% longer on average than did the control 
B cells (  Fig. 3 C  ). Although many of the interactions between 
the stimulated B cells appeared to be organized around specifi  c 
sites in the LN follicle, the cells also exhibited an apparent at-
traction for each other (  Fig. 3 D  ). They sometimes sped up 
before an interaction occurred, and during the interaction the 
cell velocities usually declined. In some instances, one cell re-
versed its direction after an interaction with another cell or, 
more frequently, it paused, which could be recognized by a 
loop in the track.   Fig. 3 E   shows the tracks of 18 TLR4 ligand–
exposed B cells randomly chosen after selecting cells that re-
mained within the imaging volume a minimum of 10 min. All 
but one of the cells had at least one interaction with another 
B cell. Graphs of the instantaneous velocities of two interac-
tive LPS-exposed B cells are shown in   Fig. 3 F  . 
  TLR4 stimulation triggered a rapid expansion of B cells 
in vivo and some cells adopted a germinal center phenotype 
  The number of visible TLR4-stimulated B cells versus the 
nonstimulated B cells declined within 2–3 d after transfer. This 
could represent a decrease in the number of cells within the 
LNs or a dilution of the fl  uorescent dye in the TLR4-stimulated 
B cells as a consequence of cell division. To test whether 
the B cells proliferated in vivo, we transferred CFSE-labeled 
of G  i    2   and Rgs1 in regulating the output from chemokine 
receptor engagement (  Moratz et al., 2004  ;   Han et al., 2005  ; 
  Hwang et al., 2007  ), we also checked the eff  ect of LPS expo-
sure on their expression. LPS stimulation increased   Gnai2   
expression, which will augment chemokine receptor signal-
ing, and reduced   Rgs1   expression, which should have the 
opposite eff  ect, providing another reason why these cells ex-
hibit strong chemotactic responses (Fig. S1 C). To test 
whether these changes translated into improved LN homing, 
we diff  erentially labeled the TLR4 ligand–treated and con-
trol B cells and transferred them intravenously to recipient 
mice. 2 h later, we harvested LNs and spleen and sampled the 
blood of the recipient mice. We recovered     40% more 
TLR4-stimulated B cells from the LNs than from control cells 
and slightly fewer cells from the blood and spleen (  Fig. 1 D  ). 
  Next, we determined whether the TLR4 ligand exposure 
aff  ected LN transit time by transferring B cells previously cul-
tured with LPS, or not, to recipient animals and, 2 h later, 
treating the mice with L-selectin antibody, inhibiting further 
entrance of B cells into the LNs. We harvested the popliteal 
LNs (pLNs) and inguinal LNs (iLNs) and sampled the blood 
either 12 or 24 h later (  Fig. 1 E  ). The ratio between the num-
bers of cells in the LNs from the L-selectin–treated mice at 
12 and 24 h versus those in the nontreated mice at 2 h is related 
to the mean transit time of the cell population. Surprisingly, 
the results showed only a slight enhancement in the retention 
of the stimulated B cells compared with the nonstimulated 
cells at 12 h, and by 24 h there was little diff  erence (  Fig. 1 F  ). 
Because we only examined the egress of those cells that had 
entered into the LNs within 2 h of transfer, our analysis is bi-
ased toward those cells that rapidly accessed LNs. 
  TLR4 ligand exposure changed the migratory behavior 
of B cells in the LN follicle 
  To investigate the migration dynamics of TLR4-stimulated 
B cells, we transferred diff  erentially labeled LPS-stimulated or 
nonstimulated B cells into recipient mice. At various times after 
transfer, we visualized and tracked the movement of the cells by 
imaging them in the iLN intravitally using TP-LSM (  Fig. 2, 
A and B  ).   At 1 d after transfer, both B cell populations had lo-
calized in the LN follicle; however, the TLR4 ligand–exposed 
B cells (  Fig. 2, A and B  , green) tended toward the follicle cen-
ter. Readily distinguishable from the nonactivated cells (  Video 1  , 
red), the larger TLR4-stimulated B cells often displayed a highly 
polarized morphology (  Video 1  , green). At days 2 and 3 after 
transfer, the stimulated B cells (  Fig. 2 A  , green) maintained their 
preference for the follicle center (  Fig. S2  ) and continued to 
exhibit morphological diff  erences from the nonactivated cells 
(  Fig. 2 A  , red). At later time points, we transferred CFSE-labeled 
B cells that were either nonactivated or TLR4 stimulated into 
diff  erent mice. 4 d later we separately imaged them. As we had 
observed at earlier time points, the non-TLR4 ligand–exposed 
cells remain uniformly distributed throughout the follicle (not 
depicted); however, the TLR4-stimulated cells no longer showed 
a preference for the center of the follicle and many cells lined up 
along the follicle edge (  Fig. 2 B  , green). 2646 TLR4-activated B cells in germinal centers   | Hwang et al. 
  Figure 3.    TLR4 ligand exposure triggers extensive B cell interactions in the LN follicle.   (A) B cell clusters. MIP from TP-LSM of TLR4-stimulated 
B cell clusters (red circles) 1 d after transfer. Two separate regions (top and bottom) are shown. Bar, 20 μm. (B) Tracking clustered B cells. MIP and tracks of 
TLR4-stimulated B cell (green) 48 h after transfer. White circles indicate highly interactive cells and the time colored tracks (red, blue, and yellow) show 
movement of the TLR4-stimulated B cells over 20 min. Arrows point to several representative tracks. Bar, 20 μm. (C) Quantifi  cation of cell–cell interac-
tions. The durations in which LPS-activated B cells contacted other activated B cells or nonstimulated B cells contacted other nonstimulated B cells are 
shown (left). Each cell was tracked for 15 min and the number of interactions is shown (right). Black bars indicate mean values (*, P < 0.05). (D) B cell–B 
cell interactions (arrows). MIPs of intravital TP-LSM of TLR4-stimulated B cells 72 h after transfer in the iLN. Image spaces are 130 × 115 × 33 μm (fi  rst 
and second) and 130 × 130 × 33 μm (third and fourth). Individual cells were tracked every 30 s for 30 min and their previous 20 positions are indicated 
by a dragon tail. Three frames from two sets of imaging data showing colliding LPS-stimulated B cells at various time points during the imaging. Track 1 
is further analyzed in F. Bar, 20 μm. (E) Tracking interacting B cells. Tracks of TLR4-stimulated B cells 72 h after transfer. Imaging space is 240 × 190 × 33 μm. 
Individual tracks were sorted by duration and the top 18 of 60 tracks were selected. Interactions with other TLR4-stimulated B cells (both selected JEM VOL. 206, November 23, 2009 
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by intravital TP-LSM. Within the iLNs of immunized mice, 
we found several large clusters of B cells which were signifi  -
cantly larger than those we had observed previously (  Fig. 5 A  , 
top left).   To determine the location of the cell clusters in rela-
tion to germinal centers, we injected a labeled FDC-M2 
monoclonal antibody subcutaneously the day before imaging. 
cells and counted the number of recovered cells and analyzed 
their CFSE expression profi  le control (  Hawkins et al., 2007  ; 
  Quah et al., 2007  ). We recovered more TLR4 ligand–exposed 
B cells than control cells in the spleen, iLN, and pLN at days 2, 
3, and 4 (  Fig. 4 A  ).   The number of nonstimulated cells remained 
relatively constant for the 5 d that we analyzed. The number of 
TLR4-stimulated B cells peaked at day 3 in the spleen and at 
day 4 in the LN. The CFSE profi  les of the cells recovered from 
the spleen, popliteal, and iLN showed that some of the B cells 
exposed to LPS 5 d previously, which was 4 d after transfer, had 
signifi  cantly diluted their levels of CFSE, which is consistent 
with ongoing proliferation (  Fig. 4 A   and not depicted). This 
contrasted with the day-4 control B cells harvested from the 
spleen and LN, which had not diluted their CFSE. 
  To verify these results and to provide additional pheno-
typing data, we analyzed the cell recovery and CFSE profi  les 
of TLR4 ligand–exposed CD45.1 B cells transferred into 
CD45.2 mice. Besides checking the transferred cells in the 
LNs and spleen, we also examined their presence in bone 
marrow. Compared with the initial experiments, we found a 
more marked expansion of the TLR4 ligand–exposed B cells. 
This is presumably the result of an inability to recognize some 
of the transferred cells in the fi  rst experiment because of dye 
dilution. Using CD45.1-marked cells, we observed an     40-
fold increase in the number of cells between days 1 and 7 in 
the spleen, a 15-fold increase in the LN, and a twofold in-
crease in the bone marrow (  Fig. 4, B–D  ). Again many of the 
transferred cells markedly diluted their CFSE expression. We 
recovered B220  +  IgD  high   and B220  +  IgD  low   B cells from all 
three sites. The B220  +  IgD  high   bone marrow cells recovered 3 d 
after transfer had not diluted their CFSE to the same degree 
as the B220  +  IgD  high   B cells recovered from the spleen and 
iLN. We also found that a portion of the cells had adopted 
a germinal center B cell phenotype being IgD  low  GL7  +  Fas  +  . 
Surprisingly, we also found these cells in the bone marrow. 
By day 9 after transfer the number of recovered cells de-
clined, suggesting that some of the cells had died, although 
the numbers of IgD  low  GL7  +  Fas  +   cells remained relatively sta-
ble in the spleen and LN. 
  Recruitment of TLR4-activated B cells into ongoing 
germinal center reactions 
  For several reasons, it is of interest to determine whether LPS-
activated B cells joined ongoing germinal center reactions. 
Recent imaging studies had revealed that follicular B cells can 
enter into the light zone of germinal centers (  Schwickert et al., 
2007  ), and we had noted that some of the LPS-stimulated 
B cells adopted a germinal center phenotype in vivo. Therefore, 
we transferred fl  uorescently labeled TLR4 ligand–exposed B 
cells into a mouse previously immunized with hen egg lyso-
zyme (HEL) and examined the location of the transferred cells 
and nonselected) in the imaging space are indicated with arrows. Track 2 is further analyzed in F. (F) Velocity profi  les. Instantaneous velocities of two 
tracks from TLR4-stimulated B cells are shown. Cell–cell interactions are indicated by shading. The tracks are from D and E. Imaging data shown is from 
the analysis of three recipient mice.     
 
  Figure 4.    TLR4 ligand–exposed B cells proliferate in vivo and some 
adopt a germinal center phenotype.   (A) Recovered cell numbers and 
CFSE profi  les of nonstimulated and LPS-stimulated B cells. 10 × 10  6   cells 
were labeled with CFSE and transferred intravenously to different recipient 
mice. At the indicated days, the total number of viable CFSE-labeled cells 
recovered from the spleen, iLN, and pLN were determined (left). The CFSE 
profi  les of the recovered splenic cells are shown, along with the percentage 
of cells that divided (right). Data from fi  ve recipient mice that received non-
activated B cells and fi  ve that received LPS-activated B cells. (B–D) Recovery 
and phenotype of cells recovered from spleen, bone marrow, and iLN after 
transfer of LPS-stimulated CD45.1 B cells into CD45.2 mice. Number and 
phenotype of the recovered CD45.1 cells (left) and CFSE profi  les of the 
CD45.1 cells recovered at day 3 after transfer (right) are shown. Data are 
from the analysis of fi  ve recipient mice that received LPS-activated B cells.     2648 TLR4-activated B cells in germinal centers   | Hwang et al. 
  Figure 5.    TLR4 ligand–treated B cells enter ongoing germinal center reactions and focus in the dark zone.   (A) Germinal center imaging. MIPs 
of transferred TLR4-stimulated B cells (transferred 2 d before imaging) in iLN of mice immunized 1 wk previously with HEL. The top left shows a cluster of 
the TLR4-stimulated B cells (arrow) 1 wk after immunization. Also shown are images of TLR4-stimulated B cells in the light zone region, at the interface 
dark zone–light zone region, and in the dark zone region of the germinal center (bottom). Location of the cells defi  ned by FDC-M2–positive cells were JEM VOL. 206, November 23, 2009 
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FDC-M2 recognizes C4 deposited on FDCs, which densely 
pack the light zone region of germinal centers (  Taylor et al., 
2002  ). The light zone contains B cells that are termed centro-
cytes, which are the descendents of rapidly proliferating dark 
zone B cells known as centroblasts. In the absence of immu-
nization we observed scattered sites of FDC-M2 staining in 
the LN follicle (unpublished data). After immunization, we 
observed a strongly FDC-M2–reactive region in the LN folli-
cle, which is consistent with a germinal center light zone 
(  Fig. 5 A  , top center). Scattered among the FDC-M2–positive 
cells were TLR4 ligand–exposed B cells (  Video 3  ). Imaging 
deeper into the follicle, we noted increasing numbers of B cells 
and, fi  nally, a cluster of B cells in a location consistent with 
the dark zone (  Fig. 5 A  , top right and bottom left;   Video 4  ). 
The TLR4 ligand–exposed B cells within the light zone re-
gion moved sequentially from one FDC to another. The 
migratory paths of the B cells in the light zone from one ex-
periment are shown in   Fig. 5 B  . The B cells in the dark zone 
remained largely confi  ned to that region and exhibited fre-
quent B–B cell interactions (  Fig. 5 C  ). In the dark zone, cells 
moved slower than they did in the light zone or outside the 
germinal center. The tracks of the light zone and dark zone 
B cells had reduced displacements and decreased straightness 
compared with the follicular but nongerminal center cells 
(  Fig. 5, D and E  ). Plotting the instantaneous velocities of the 
light zone B cells that interacted with FDCs and dark zone 
B cells that interacted with each other revealed that the B 
cells slowed when they interacted with another cell (  Fig. 5 F  ). 
We confi  rmed the location of the transferred LPS-stimulated 
cells in the dark zone of germinal centers by immunohisto-
chemistry (  Fig. S3  ). 
  TLR4 ligand–exposed B cells competed effi  ciently 
with antigen-specifi  c B cells for entrance, divided 
within the dark zone, and many remained within the dark 
zones of splenic germinal centers 
  Entrance into the dark zone of germinal centers has been 
thought to be restricted to antigen-activated B cells, whereas 
non–antigen-specifi   c B cells can only visit the light zone 
(  Schwickert et al., 2007  ). To directly compare antigen-specifi  c 
B cells and TLR4 ligand–exposed B cells in their ability to 
access the dark zone region of preexisting germinal center, 
we transferred equal numbers of diff  erentially labeled LPS-
exposed C7Bl/6 B cells and HEL-transgenic B cells into re-
cipient mice that had been immunized 10 d earlier with HEL. 
Imaging the iLN of recipient mice 2 d after transfer revealed 
that in all the visible germinal centers, the number of TLR4 
ligand–stimulated B cells far exceeded the number of antigen-
specifi  c B cells in the dark zone region (  Fig. 6 A   and   Video 5  ).   
This, in part, refl  ects the better effi   ciency with which the 
TLR4-stimulated B cells enter LNs, but tracking individual 
TLR4-stimulated and transgenic B cells indicated that rela-
tively few antigen-specifi  c B cells had entered the dark zone 
at this time point (  Fig. 6 A  , right). 
  In the course of imaging the TLR4-stimulated B cells 
within the dark zone of germinal centers we noted numerous 
dividing cells (  Video 6  ). Images captured during intravital 
microscopy showed three cells in the dark zone that divided 
during a 45-min imaging session. The individual cells are 
highlighted (  Fig. 6 B  , left). Serial zoomed images show the 
cell outlined in the yellow box dividing (  Fig. 6 B  , right). The 
cell has rounded up in the 9:00-min image and begins to di-
vide in the 28:00-min image. The daughter cells remained 
adjacent for the duration of the imaging period. 
  Next, we determined whether the TLR4 ligand–exposed 
B cells entered splenic germinal centers. To do so, we trans-
ferred TLR4-stimulated GFP-positive B cells and CMF  2  HC-
labeled nonstimulated B cells to recipient mice immunized 
7 d previously with HEL and injected the mice with fl  uores-
cently labeled FDC-M2 antibody (red). 4 d later, we pre-
pared thick frozen sections of the spleens of recipient mice 
and examined the location of the transferred cells by TP-LSM. 
We found that the injected FDC-M2 antibody allowed us to 
identify the germinal centers in the splenic section. The dark 
zones were defi  ned on the basis of their location in relation 
to the FDC-M2–staining cells. We found numerous germinal 
centers in which the previously TLR4-stimulated B cells 
had accessed and accumulated within the dark zone regions. 
In contrast, the control cells failed to access the dark zones of 
germinal centers (  Fig. 6 C  ). 
  TLR4-stimulated B cells augmented an antigen-stimulated 
antibody response and persisted after transfer in the bone 
marrow, spleen, and LN 
  To examine whether TLR4 ligand–exposed cells can aug-
ment an ongoing immune response, we immunized CD45.2 
mice with HEL and, 1 wk later, transferred either TLR4 ligand–
stimulated CD45.1 B cells or nonstimulated CD45.1 B cells. 
revealed by Alexa Fluor 488–labeled FDC-M2 injected 1 d before imaging. Bars, 50 μm. (B) Tracking. TLR4-stimulated B cells within the germinal center 
light zone. TLR4-stimulated cells imaged intravitally (FDC-M2, green; TLR4-stimulated B cell, red) were tracked for 20 min. Tracks (white) are from those 
cells that remained in the imaging space for at least 10 min. Bar, 50 μm. (C) Dark zone interactions. A single slice is shown from intravital TP-LSM show-
ing the location of TLR4-stimulated B cells in the dark zone region. The centers of each cell are indicated with a gray ball. Three pairs of interacting B cells 
are indicated with white arrows. In one pair the centers were superimposed. Bar, 20 μm. (D) Motility parameters. Cell motilities in light zone (LZ), in dark 
zone (DZ), and outside of the germinal center (Non-GC) were determined. Each data point represents a single cell and blue, red, and yellow bars indicate 
mean values (**, P < 0.05). (E) Tracks. Shown are superimposed tracks of TLR4-stimulated cells of each indicated type in the x, y plane setting the starting 
coordinates to the origin. Tracks of 30 cells in the indicated sites tracked for 15 min of a 20-min imaging experiment. (F) Velocity profi  les. Magnitudes are 
shown of the instantaneous velocities of TLR4-stimulated B cells in the light zone and the dark zone. An interaction with another cell is indicated by 
shading. Experiments were performed fi  ve times using multiple recipient mice.     
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  Figure 6.    TLR4 ligand–stimulated B cells that have entered the dark zone can compete effi  ciently with antigen-specifi  c B cells for dark 
zone entrance and can divide and persist in the spleen.   (A) Competition. Fluorescently stained HEL-transgenic B cells (blue) and LPS-pulsed B cells 
(green) were adoptively transferred into a recipient mouse immunized 10 d previously with HEL. FDC-M2 antibody was injected 1 d later, and the next day 
intravital TP-LSM intravital imaging was performed. An MIP image from TP-LSM intravital imaging of the iLN is shown on the left. The tracking of JEM VOL. 206, November 23, 2009 
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TLR4-stimulated B cells can augment the specifi  c antibody 
response to thymus-dependent antigen, and some of the pre-
viously TLR4-stimulated B cells or their progeny can be re-
covered weeks later in the spleen, LN, and bone marrow. 
  DISCUSSION 
  The germinal center reaction generates memory B cells and 
long-lived plasma cells that produce antibodies with a high 
affi   nity for pathogens. This response helps eliminate persistent 
infections, provides protection against future encounters with 
the same or, in some instances, related pathogens, and helps 
to diversify the antibody repertoire. However, because of the 
complexity of this response, germinal centers are often a site 
of pathology. Many B cell lymphomas arise from germinal 
center B cells, germinal centers can generate autoreactive B 
cells, and excessive numbers and ectopic germinal centers of-
ten accompany autoimmune illnesses and chronic infl  amma-
tory conditions (  Luzina et al., 2001  ;   Aloisi and Pujol-Borrell, 
2006  ;   Klein and Dalla-Favera, 2008  ). In this study, we show 
that exposure to the TLR4 ligand LPS induced signifi  cant 
alterations in B lymphocyte traffi   cking and behavior within 
LNs. Surprisingly, in both LNs and the spleen previous expo-
sure of B cells to LPS led to the recruitment of B cells into 
preexisting germinal centers, overcoming the restriction that 
limits the access of non–antigen-reactive B cells to the germi-
nal center dark zone. 
  The evidence that exposure to a TLR4 ligand alters B 
lymphocyte traffi   cking is considerable. Flow cytometry re-
sults showed enhanced expression of CXCR3-6, CCR7, 
CCR9, L-selectin, CD11a, and ICAM-1, chemotaxis data 
showed enhanced responses to the cognate chemokines of 
these receptors, and homing data revealed a superior homing 
of the TLR4 ligand–treated B cells to LNs. In addition, LPS 
stimulation decreased the   Rgs1/Gnai2   ratio, which will aug-
ment chemokine receptor signaling. This contrasts with hu-
man bone marrow–derived DCs, where LPS stimulation 
increased the ratio (  Shi et al., 2004  ). Somewhat surprisingly, 
we found that LPS activation did not signifi  cantly delay the 
transit time of B cells through the iLNs and pLNs. This was 
despite decreased   S1pr1   messenger RNA expression after LPS 
stimulation (unpublished data). Although those B cells ex-
posed to LPS have an enhanced propensity to enter LNs, they 
are not confi  ned to the LNs and spleen but, likely, continue 
to recirculate. 
  The behavior of the TLR4 ligand–treated B cells within 
the LN diff  ered signifi  cantly from either antigen-activated or 
We measured specifi  c Ig response in serum samples collected 
3 wk after the cell transfer and again 10 d after boosting 
with HEL. We found that the addition of the TLR4 ligand–
stimulated cells increased the HEL-specifi  c IgM response 50% 
and the HEL-specifi  c IgG1 response 15% compared with 
nonstimulated cells. The transfer of TLR4-activated B cells 
increased the HEL-specifi  c IgG2a and IgG2b responses at day 
28 (    25%) but did not enhance the levels achieved after re-
exposure to antigen (  Fig. S4  ). To determine the location of 
the transferred cells after antigen boosting (day 38 after trans-
fer), we performed immunohistochemistry using either 
CD35 and CD45.1 or MAdCAM-1 and CD45.1. CD35 al-
lows distinction of the B and T cell zones, whereas MAd-
CAM-1 delineates the marginal sinus. We found numerous 
transferred CD45.1 cells in the spleens from mice that had 
received TLR4-stimulated B cells, which contrasted with 
the relative paucity in the spleens of mice that had received the 
non–TLR4-stimulated CD45.1 cells (  Fig. 7  ).   Many of the 
previously stimulated CD45.1 cells resided in the B cell folli-
cles and in the marginal zones of the CD45.2 mice (  Fig. 7  ). 
In addition, we found CD45.1 cells in ongoing germinal 
centers in the spleens of mice that had received an antigen 
boost 10 d previously. Approximately 30% of the splenic ger-
minal centers contained CD45.2 cells. In some instances, the 
majority of the cells within a germinal center were of CD45.2 
origin, whereas in others we detected only a few or no 
CD45.2 cells (  Fig. S5  ). 
  We used one fi  nal approach to assess the persistence and 
fate of the transferred LPS-stimulated B cells: we transferred 
GFP-expressing B cells that had been stimulated, or not, into 
mice immunized 1 wk previously with HEL in one fl  ank. 
2 wk later the mice were boosted with HEL antigen at the 
same site, and 4 wk after the boost we collected bone mar-
row, iLN, and spleen to analyze the numbers and phenotypes 
of the recovered cells. Previous TLR4 stimulation enhanced 
the recovery of B220  +  , B220  +  CD138  +  , B220  +  IgG1  +  , and 
B220  lo  IgG1  +   cells from the spleens, LNs, and bone marrows 
when compared with the recovery of similar phenotyped 
nonstimulated B cells. For example, in the spleens we recov-
ered 7-fold more B220  +  , 2-fold more B220  +  CD138  +  , 10-
fold more B220  +  IgG1  +  , and 2-fold more B220  lo  IgG1  +   cells. 
In those mice that received LPS-stimulated B cells, we re-
covered fi  vefold more B220  +   and B220  +  CD138  +   cells from 
the iLN on the immunized side as compared with the non-
immunized side and 50-fold more B220  +  IgG1  +  -positive cells 
(  Fig. 8  ).   Together, these results indicate that the transfer of 
LPS-stimulated and transgenic B cells is shown on the right. The location of the B cells at the beginning of the tracking is shown with a green (LPS stimulated) or 
blue (not stimulated) ball. Bar, 100 μm. (B) B cells dividing in the dark zone. MIP from intravital TP-LSM imaging of the dark zone of a germinal center 
showing three cells that divided during 20 min of imaging. White squares show three cells in the dark zone that divided during a 45-min imaging. 
Zoomed images from the TP-LSM imaging, which are focused on the cell outlined in yellow in the left, are shown on the right. The arrows indicate cell 
dividing. Bar: (left) 40 μm; (right) 50 μm. (C) Persistence in the spleen. TP-LSM images of cryostat sections of spleen. Fluorescently stained B cells (blue) 
and LPS-stimulated GFP-B cells (green) were adoptively transferred into the recipient mouse immunized 7 d previously with HEL. 4 d later, 10 μg of la-
beled anti–FDC-M2 antibody (red) was injected subcutaneously. The following day, spleen was collected, fi  xed, and cryostat sections prepared. The image 
on the left was acquired with a 10× lens and the image on the right was acquired with a 40× lens. GC, germinal center. Bar: (left) 100 μm; (right) 50 μm. 
The experiment was performed twice with similar results.     
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nonstimulated cells. Normally, B cells enter the LN follicle 
and distribute uniformly throughout, whereas antigen stimu-
lation causes B cells to localize along the LN follicle border 
with the T cell zone (  Okada et al., 2005  ). B cells stimulated in 
vitro with anti-IgM and transferred to recipient animals also 
localize along the B/T cell border (unpublished data). In contrast, 
the transferred TLR4-stimulated B cells localized away from 
the B/T cell border more in the center of the LN follicle. The 
distribution of antigen-activated B cells along the B/T border 
is caused, at least in part, by an increased CCR7 expression rela-
tive to CXCR5 promoting migration toward the CCR7 li-
gands in the T cell zone (  Reif et al., 2002  ;   Okada et al., 2005  ). 
  Figure 7.    LPS-activated transferred B cells accumulate in the recipient spleens.   (A and B) Transferred LPS-activated B cells are found in the B cell 
follicle and the marginal zone of the spleen. Three groups of fi  ve mice (6 wk old, C57BL/6 CD45.2) were injected subcutaneously on day 0 with 100 μg HEL in 
CFA. 15 million cells of LPS-activated or nonactivated B cells from C57BL/6 CD45.1 mice were injected intravenously to recipient mice on day 7. Mice were 
boosted on day 28 with 100 μg HEL antigen. On day 38, the mice were sacrifi  ced and the spleens analyzed by immunohistochemistry to detect CD35 and 
CD45.1 (10× and 20×; A) and to detect MAdCAM-1 versus CD45.1 (20×; B). Bars, 100 μm. The experiment was performed with fi  ve mice with similar results.    JEM VOL. 206, November 23, 2009 
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similar, yet the treated B cells exhibited signifi  cantly more 
contacts. The increased interactions could arise from B–B 
cell communication potentially mediated by production of 
chemoattractants or by confi  nement of TLR4 ligand–exposed 
B cells by stromal cell interaction. Supporting the former ex-
planation, several studies have shown that activated B cells 
produce chemokines (  Schaniel et al., 1998  ,   1999  ). 
  Based on cell counting and CFSE dilution studies, many 
of the TLR4-stimulated B cells rapidly expanded after trans-
fer; however, after the fi  rst week the numbers of recovered 
transferred cells began to decline. In another set of experi-
ments using GFP-labeled cells, we recovered     10-fold more 
B220-positive cells from the spleen and LNs of mice 6 wk af-
ter transfer of LPS-stimulated B cells as compared with non-
stimulated B cells. These data suggest that periodic exposure 
to TLR4 ligands may substantially skew the B cell popula-
tions in the spleen and LNs. This may arise both as a conse-
quence of the proliferative potential of TLR4-stimulated cells 
and their ability to compete for survival signals as compared 
with nonstimulated cells. 
  Recent in vivo imaging of germinal centers revealed a 
dynamic open structure where follicular B cells frequently 
visited the FDC-rich germinal center light zone but not the 
germinal center dark zone (  Schwickert et al., 2007  ). Within 
the dark zone, antigen-reactive B cells had a signifi  cantly de-
creased speed, increased cell volume, and greater confi  ne-
ment than did non–antigen-reactive B cells in the follicle 
(  Allen et al., 2007  ;   Hauser et al., 2007  ;   Schwickert et al., 
2007  ). Although not antigen activated, the LPS-exposed 
B cells readily entered the dark zone of ongoing germinal 
centers, where they divided and persisted. Similar to antigen-
activated B cells in the dark zone, the TLR4 ligand–exposed 
B cells exhibited evidence of physical restriction. These results 
show that antigen activation is not a requirement for B cells 
to enter the dark zone. TLR4 engagement and subsequent B 
cell activation likely induces or up-regulates the expression of 
chemoattractant receptors that can recruit B cells into the 
dark zone. CXCR4 has been previously suggested as a possi-
bility (  Allen et al., 2004  ), although we observed only a mod-
est increase in CXCR4 expression after LPS exposure. 
Within the dark zone, TLR4 ligand–exposed B cells will fi  nd 
themselves in an environment where they can proliferate, 
undergo class switching, and, perhaps, undergo somatic hy-
permutation. Treatment of B cells with LPS is known to in-
crease expression of the enzyme activation-induced cytidine 
deaminase (AID;   Muramatsu et al., 2000  ) and we verifi  ed 
that this was the case in our experiments (unpublished data). 
AID expression is necessary for the somatic hypermutation 
and Ig switch recombination that occurs within germinal 
centers (  Muramatsu et al., 2000  ). However, although in vitro 
LPS stimulation is suffi   cient to trigger class switch recombi-
nation it does not induce mutations in Ig variable genes. 
Other signals, likely present within the dark zone, may alter 
AID activity allowing somatic hypermutation. 
  What is the fate of a dark zone germinal center B cell that 
lacks an antigen receptor reactive with the antigens that 
Before transfer, the TLR4 ligand–stimulated B cells had in-
creased both CCR7 and CXCR5 expression, although they 
exhibited a more exaggerated chemotactic response to CXCL13 
than to CCL19. Although this may account for their position-
ing with the follicle, these cells also had increased their expres-
sion of CXCR3 and acquired responsiveness to CXCR3 
ligand. Suggesting that this may be important, a recent micro-
array experiment demonstrated that FDC-enriched spleno-
cytes expressed the CXCR3 ligand CCL10 in addition to 
CXCL13 and CXCL12 (  Huber et al., 2005  ). 
  Both B cell–B cell contacts and B cell–stromal cell inter-
actions aff  ect the motility pattern of the TLR4-stimulated B 
cells within the LN follicle. They exhibited nearly twice as 
many interactions with their counterparts than did the non-
treated control cells, and the mean duration of the interac-
tions was nearly twice as long. Tracking individual cells 
reveals that many of the B–B cell interactions caused signifi  -
cant pausing or abrupt direction changes. At least a portion of 
the interactions between the TLR4 ligand–treated B cells are 
likely to be nonrandom. At later time points, the density of 
visible LPS-treated B cells within the imaging space was 
lower than the nontreated cells and the velocity profi  les were 
  Figure 8.    TLR ligand–exposed B cells differentiated into CD138 
plasma and IgG1-positive B cell.   LPS-activated or nonactivated B cells 
were prepared from GFP mice and transferred into mice immunized 1 wk 
previously with HEL in CFA. 21 d after immunization, mice were boosted 
with 100 μg HEL in PBS. 4 wk after boosting, spleen, iLN (immunized and 
nonimmunized side), and femurs (bone marrow) were removed, gently 
dissociated into single cell suspensions, and subjected to fl  ow cytometry 
to analyze GFP, B220, IgG1, or CD138 as indicated. The data shown is 
mean ± SD from four recipient mice that received non–LPS-activated 
B cells and four recipient mice that received LPS-activated B cells. The 
horizontal bars indicate mean values.     2654 TLR4-activated B cells in germinal centers   | Hwang et al. 
  MATERIALS AND METHODS 
  Mice.     C57BL/6, B6.SJL-Ptprc  a   Pepc  b  /BoyJ, C57BL/6 (B6)-
Tg(IghelMD4)4Ccg/J, and C57BL/6-Tg(UBC-GFP)30Scha/J mice were 
obtained from The Jackson Laboratory or Taconic. All mice used in this 
study were 6–12 wk of age. Mice were housed under specifi  c pathogen-free 
conditions. All the animal experiments and protocols used in this study were 
approached by the National Institute of Allergy and Infectious Diseases Ani-
mal Care and Use Committee at the National Institutes of Health. 
  Cell culture.     Splenic B cells were isolated by negative depletion using bio-
tinylated antibodies to CD4, CD8, Gr-1 (Ly-6c and Ly 6G), and CD11c and 
Dynabeads M-280 Streptavidin (Invitrogen) as previously described (  Hwang 
et al., 2007  ). The B cell purity was >95%. B cells were cultured in RPMI 
1640 containing 10% FBS (Invitrogen), 2 mM L-glutamine, antibiotics (100 
IU/ml penicillin and 100 μg/ml streptomycin), 1 mM sodium pyruvate, and 
50 μM 2-mercaptoethanol. For the in vitro stimulation of B cell, B cells 
were treated or untreated with 1 μg/ml LPS (from   Escherichia coli   055:B5; 
Sigma-Aldrich) overnight. The cells were cultured in T25 fl  asks at a concen-
tration of two million cells/ml. Subsequently, the cells were collected and 
washed three times with PBS. The viability of the cells was determined by 
propidium iodide staining before analysis or cell transfer. 
  Flow cytometric analysis.     TLR4-stimulated or nonactivated cell suspen-
sions were stained with antibodies. Antibodies used were the following: biotin-
conjugated antibody to CCR7 (BioLegend), anti-CXCR4, anti-CXCR5, 
anti-CD62L, anti-CD11a, anti-CD49d, anti-CD138, anti-GL7 (BD), and anti-
ICAM-1 (BioLegend), FITC-conjugated anti-GL-7, anti-CD4, and anti-
CD8 (BD), PE-conjugated anti-CCR9, anti-CXCR3, anti-CXCR6 (R&D 
Systems), anti-CD138, anti-CD4, anti-CD8 (BD), and IgD (eBioscience), 
PE-Cy7–conjugated anti-CD95, allophycocyanin-conjugated anti-B220 
and anti-IgG1 (BD), Pacifi  c blue–conjugated anti-B220, Alexa Fluor 647 
anti–GL-7, and Alexa Fluor 750 anti-CD45.1. Streptavidin-PE and PerCP-
Cy5.5 were obtained from BD. Data were collected on a FACSCalibur or 
CANTO II (BD) and analyzed with FlowJo software (Tree Star, Inc.). The 
CFSE dilution studies were performed according to a previously published 
protocol (  Hawkins et al., 2007  ;   Quah et al., 2007  ) and analyzed with FlowJo 
software. 
  Chemotaxis.     Chemotaxis assays were performed using a transwell chamber 
(Costar; Corning) as previously described (  Moratz et al., 2004  ). After being 
LPS activated or not, the B cells were washed twice, resuspended in com-
plete RPMI 1640 medium, and added in a volume of 100 μl to the upper 
wells of a 24-well transwell plate with a 5-μm insert. Lower wells contained 
various doses of chemokines in 600 μl of complete RPMI 1640 medium. 
For chemotaxis with CXCL9 and CXCL16, splenic CD4 T cells were acti-
vated with 2 μg of anti-CD3 plus 10 ng/ml of recombinant mouse IL-2 for 
24 h. CD4 single-positive thymocytes were used for some of the chemotaxis 
assays with CCL25. The numbers of cells that migrated to the lower well af-
ter either a 2 or 3 h incubation were counted using a fl  ow cytometer. The 
LPS-stimulated B cells had a slightly higher basal migration in the absence of 
chemokine (    8 vs. 5%). Specifi  c chemotaxis is the percentage of cells that 
migrated into the bottom chamber in the presence of chemokine minus the 
percentage of cells that migrated in the absence of chemokine. 
  RT-PCR.     RNA was isolated with the TRIZOL reagent (Invitrogen) accord-
ing to the manufacturer’s instructions. Complementary DNA was synthesized 
from 1 μg RNA with the Omniscript RT kit (QIAGEN) with Omniscript 
reverse transcription according to the manufacturer’s instructions. For PCR, 
1 μl of the complementary DNA was placed in fi  nal volume of 50 μl containing 
HotStarTaq Plus Master Mix (QIAGEN) and RNase-free water and primers. 
The following primer pairs were used:     -actin, 5    -CCTAAGGCCAACC-
GTGAAAAG-3     and 5    -TCTTCATGGTGCTAGGAGCCA-3    ;   Rgs1  , 
5    -GATCCCACATCTGGAATCTGG-3     and 5   -GCTGTCGATTCTCG-
AGTATGG-3    ; and   Gnai2  , 5    -CTCTAAAATGATCGACAAGAACCT-3     
and 5    -ACATCTTGAAGTGTAAGTCCTTGA-3    . The PCR amplifi  cations 
elicited the formation of the germinal center? Those cells 
that enter relatively young or mixed germinal centers are 
likely to have a better chance of survival than those entering 
a well established germinal center already populated with 
high-affi   nity B cells. In younger germinal center, some of 
the LPS-exposed B cells may acquire antigen receptors that 
allow them to compete with antigen-activated B cells for 
survival signals. In fact, after antigen boosting we could fi  nd 
germinal centers that contained transferred cells. In addition, 
because lower affi   nity germinal center B cells tend to be 
shunted toward the memory B cell compartment (  Paus et al., 
2006  ;   Benson et al., 2007  ;   Tarlinton, 2008  ), feeding germi-
nal center dark zones with randomly activated B cells could 
generate low-affi   nity memory B cells that would further di-
versify the antibody repertoire. Consistent with that possibil-
ity, we found that the addition of TLR4-stimulated B cells 
to previously immunized mice resulted in a signifi  cant in-
crease in the number of B220  +  IgG1  +   cells compared with 
the mice, which received nonstimulated cells. A large num-
ber of the TLR4-stimulated B cells localized in the marginal 
zone, a site known to accumulate memory B cells (  Liu et al., 
1988  ). However, because memory B cells can arise in the 
absence of germinal center formation, whether these cells 
previously visited a germinal center remains unknown 
(  Anderson et al., 2007  ). Finally, a signifi  cant proportion of 
the TLR4 ligand–treated B cells that enter the dark zone 
may not receive survival signals and die, although engage-
ment of TLR4 provides some survival signals not conferred 
by antigen activation (  Souvannavong et al., 2004  ). In the 
setting of autoimmunity where B cell tolerance check points 
in the germinal center may have failed (  Cappione et al., 
2005  ;   William et al., 2006  ), germinal center dark zones may 
be replenished by TLR-stimulated B cells, some likely to be 
autoreactive and perhaps even anergic. There the cells may 
fi  nd themselves in an environment that promotes their ex-
pansion and diff  erentiation. 
  In conclusion, the observations and analyses reported 
here suggest that TLR4 signaling directs peripheral B cells 
to rapidly locate within LNs and the splenic white pulp. It 
likely does so by enhancing chemokine receptor expression, 
increasing the expression of L-selectin, and biasing the sig-
naling pathway toward heightened responsiveness. Within 
the LN follicle, the TLR4 ligand–treated B cells exhibit be-
havior that is signifi  cantly diff  erent from nonstimulated or 
antigen-stimulated B cells. The TLR4-activated cells pre-
dominantly reside in the center of the LN follicle where 
they can directly interact with each other. The expansion of 
these cells in vivo suggests that these contacts may provide 
signals that help maintain the activated phenotype. If an LN 
follicle contains a germinal center, exposure to a TLR4 li-
gand will promote the entrance of stimulated B cells into 
the dark zone. TLR signaling may further fuel ongoing ger-
minal center responses, providing a mechanism that aug-
ments the polyclonal expansion of the B cells which occurs 
after exposure to infectious agents and during the course of 
autoimmune illnesses. JEM VOL. 206, November 23, 2009 
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into recipient mice. After 2 h, spleen, iLNs, and pLNs were removed and 
gently dissociated into single cell suspensions. Peripheral blood was collected 
by retro-orbital eye bleeding. After removing red blood cells with Tris-
NH  4  Cl, the cells were resuspended in PBS containing 1% BSA at 4°C. Flow 
cytometric analysis was performed on a FACSCalibur or CANTO II and the 
data were analyzed using the FlowJo software. Forward and side scatter pa-
rameters were used to gate on live cells. 
  LN transit assay.     The assay was performed as previously described (  Han 
et al., 2005  ). LPS-activated or non–LPS-activated B cells from C57BL/6 were 
labeled with 2 μM CMFDA or 2.5 μM CMTMR for 15 min at 37°C and 
7–20 million viable cells of each population were injected intravenously to 
recipient mice. 2 h later, the mice were injected intravenously with either 
PBS or anti–L-selectin antibody (100 μg/mouse). After 12 and 24 h, iLNs 
and pLNs were removed and gently dissociated into single cell suspensions. 
Peripheral blood was collected by retro-orbital eye bleeding. After removing 
red blood cells with Tris-NH  4  Cl, the cells were resuspended in PBS con-
taining 1% BSA at 4°C. Flow cytometric analysis was performed on a FAC-
SCalibur or CANTO II and the data were analyzed using FlowJo software. 
Forward and side scatter parameters were used to gate on live cells. 
  Measurement of HEL-specifi  c antibody responses.     Two groups of fi  ve 
mice (6 wk old, C57BL/6 CD45.2) were injected subcutaneously on both 
sides of the iLN on day 0 with 100 μg HEL in CFA (HEL + CFA, 1:1 vol/
vol in stable emulsion) in a 100-μl fi  nal volume. 15 million cells of LPS-
activated or non–LPS-activated B cells from C57BL/6 CD45.1 mice were in-
jected intravenously into recipient mice on day 7. Mice were boosted on day 
28 with 100 μg Hel antigen. They were bled on day     1, day 28, and day 38 
from mouse tail. Serum was obtained after clotting at room temperature and 
centrifugation for 5 min at 10,000   g  . HEL-specifi  c antibody responses were 
assayed by ELISA, as described in   Moratz et al. (2004)  . In brief, 96-well 
ELISA plates (Costar) were coated with 10 μg/ml Hel antigen (Sigma-
Aldrich) overnight at 4°C, washed, and blocked with 1% bovine serum al-
bumin fraction V (Sigma-Aldrich). Serial dilutions of serum were then added 
to the plates and incubated 4 h at 4°C. After washing, alkaline phosphatase–
conjugated goat anti–mouse Ig isotype antibodies (SouthernBiotech) were 
added for 2 h at room temperature. Absorbance was then measured at 
405 nm in a Flexstation 3 (MDS Analytical Technologies). The results were 
expressed as absorbance units at OD  405   ± SD. 
  Immunohistochemistry.     A similar immunization and transfer protocol was 
used as for measuring the HEL-specifi  c antibody response. Freshly isolated 
day-38 spleens were snap frozen in Tissue-Tek OCT compound (Sakura). 7-μm 
frozen OCT splenic sections were acetone fi  xed for 2 min and dried at room 
temperature. Slides were rehydrated in Tris-buff  ered saline and stained in a 
humidifi   ed chamber in Tris-buff   ered saline/0.1% BSA/1% mouse serum 
overnight at 4°C or for 1 h at room temperature. Primary antibodies included 
mouse anti–mouse CD45.1 (A20, biotinylated; BD) and Armenian hamster 
anti–mouse CD3e (145-2C11, purifi  ed; BD). Also used were rat anti–mouse 
IgD (11-26c.2a, purifi  ed; BD), rat anti–mouse CD35 (8C12, biotinylated; 
BD), and rat anti–mouse MAdCAM-1 (MECA-367, purifi  ed; BD). Biotin-
ylated antibodies were detected with streptavidin-alkaline phosphatase (Jackson 
ImmunoResearch Laboratories) and purifi  ed mAbs with AP-conjugated goat 
anti–Armenian hamster IgG (H+L; Jackson ImmunoResearch Laboratories) 
or HRP-conjugated donkey anti–rat IgG (H+L; Jackson ImmunoResearch 
Laboratories). HRP was reacted with DAB (Peroxidase Substrate kit; Vector 
Laboratories) and alkaline phosphatase was reacted with Fast blue/Napthol 
(AS-MX; Sigma-Aldrich). Levamisole (Sigma-Aldrich) was used to block en-
dogenous alkaline phosphatase activity. Slides were mounted in Crystal 
Mount (Electron Microscopy Sciences). Images were acquired with a micro-
scope (BX-50; Olympus) equipped with a ProgRes digital microscope cam-
era (Jenoptik) and assembled using Photoshop CS (Adobe). 
  Analysis of transferred GFP-positive B cells.     Two groups of four mice 
(6 wk old, C57BL/6) were injected subcutaneously near the left iLN on day 
were performed with the following protocol: 95°C for 15 min initially, fol-
lowed by 26–30 cycles of 1 min at 94°C, 1 min at 58 or 65°C, and 2 min at 
72°C, and fi  nally 1 cycle at 72°C for 10 min. The PCR products were sepa-
rated by electrophoresis in 2% agarose and visualized by staining with ethidium 
bromide. For each primer pair, the number of PCR cycles was chosen to be in 
the linear amplifi  cation range. 
  Intravital two-photon microscopy.     iLNs were prepared for intravital mi-
croscopy as previously described (  Han et al., 2005  ). Cell populations were la-
beled for 15 min at 37°C with     2.5–5 μM of red cell tracker CMTMR, green 
cell tracker CMFDA, or blue cell tracker CMF  2  HC (Invitrogen). 7–10 million 
labeled cells of each population in 200 μl of PBS were adoptively transferred 
by tail vein injection into     6–10-wk-old recipient mice. After anesthetizing 
the mice by intraperitoneal injection of 300 mg/kg Avertin (tribromoethanol; 
Sigma-Aldrich), the skin and fatty tissue over iLN were removed. The mouse 
was placed in a prewarmed coverglass chamber slide (Nalgene; Nunc). The 
chamber slide was then placed into the temperature control chamber (The 
Cube and Box; Life Imaging Services) equipped on the microscope (SP5; 
Leica). The temperature of air was monitored and maintained at 37.0°C ± 
0.5°C. iLN was intravitally imaged from the capsule over a range of depths 
(60–220 μm). Two-photon imaging was performed with an inverted fi  ve-
channel confocal microscope (SP5) equipped with a 20× multi-immersion 
objective, 0.7 NA (immersion medium used 80% glycerol). Two-photon ex-
citation was provided by a Mai Tai Ti:Sapphire laser (Spectra Physics) with 
a 10 W pump, tuned to 810 nm. Emitted fl  uorescence was collected using a 
four-channel nondescanned detector. Wavelength separation was through a 
dichroic mirror at 495 nm and then separated again through a dichroic mirror 
at 455 nm, followed by 405/20 nm emission fi  lter for second harmonics and 
480/40 nm emission fi  lter for CMF  2  HC, and a dichroic mirror at 565 nm, fol-
lowed by 525/50 nm emission fi  lter for CMFDA and 620/60 nm emission fi  l-
ter for Alexa Fluor 594 (Invitrogen). For four-dimensional analysis of cell 
migration, stacks of 4 or 10 sections (z step = 3 μm) were acquired every 15 or 
30 s to provide an imaging volume of 9 or 27 μm in depth. To visualize 
TLR4-stimulated B cells in germinal centers, B6 recipient mice were injected 
subcutaneously with 100 μg HEL (Sigma-Aldrich) in CFA. 6–10 d later, 7–10 
million LPS-activated or nonactivated splenic B cells were adoptively trans-
ferred intravenously into immunized mice and 10 μg FDC-M2 (ImmunoKon-
tact) conjugated to Alexa Fluor 594 (Invitrogen) was injected subcutaneously. 
In some instances, HEL-transgenic B cells were transferred. Imaging was per-
formed as indicated in this section. Sequences of image stacks were trans-
formed into volume-rendered four-dimensional videos using Imaris software 
(v.6.0.1; Bitplane), and the spot analysis was used for semiautomated tracking 
of cell motility in three dimensions using the following parameters: autoregres-
sive motion algorithm, estimated diameter 10 μm, background subtraction 
true, maximum distance 20 μm, and maximum gap size 3. The dataset was 
corrected for tissue drift by the Imaris software. Calculations of the cell velocity 
and displacement were performed using the Imaris software. All statistical anal-
ysis was performed with Prism (GraphPad Software, Inc.). Signifi  cance of sta-
tistics was calculated with unpaired   t   test for two nonparametric data. 
  TP-LSM images of cryostat section of spleens.     Fluorescently stained 
wild-type B cells (blue; CMF  2  HC) and 1 μg/ml LPS (overnight)-pulsed 
GFP–B cells (green) were adoptively transferred into the recipient mouse 
previously immunized with 100 μg of emulsifi  ed HEL-CFA for 7 d. 1 d be-
fore sacrifi  ce, 10 μg of Alexa Fluor 594–conjugated anti–FDC-M2 antibody 
was injected subcutaneously in the region of the iLN. 4 d after cell transfer, the 
spleen was collected and then fi  xed with a periodate-lysine-paraformaldehyde 
fi  xative solution for 12 h and then dehydrated with 30% sucrose in phos-
phate buff  er. OCT-embedded 100-μm cryostat section was mounted with 
Vectashield (Vector Laboratories) mounting medium. Imaging was per-
formed as indicated in the previous section. 
  Homing assays.     LPS-activated or nonactivated B cells from C57BL/6 
were labeled with 1 μM CMFDA or 2.5 μM CMTMR for 15 min at 37°C 
and equal numbers of viable cells (7–20 million) were injected intravenously 2656 TLR4-activated B cells in germinal centers   | Hwang et al. 
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0 with 100 μg HEL in CFA. 25 million LPS-activated or non–LPS-activated 
GFP B cells from C57BL/6-Tg(UBC-GFP)30Scha/J were injected intrave-
nously into the recipient mice on day 7. Mice were boosted on day 21 with 
100 μg HEL in PBS. At day 42, spleen, iLNs and femurs were removed and 
gently dissociated into single cell suspensions. After removing red blood cells 
with Tris-NH  4  Cl, the cells were resuspended in PBS containing 1% BSA at 
4°C. Flow cytometric analysis was performed on a FACSCanto II and the 
data were analyzed using FlowJo software. Forward and side scatter parame-
ters were used to gate on live cells. 
  Statistics.     In vivo results represent samples from three to six mice per experi-
ment. In vitro results represent mean values of sextuplet samples. All experi-
ments were performed at least three times. SD and p-values were calculated 
with the Student’s   t   test using Excel (Microsoft) or Prism software. 
  Online supplemental material.     Fig. S1 compares receptor expression of 
freshly isolated splenic B cells versus B cells stimulated with LPS overnight 
and shows the enhanced chemotactic responses of the LPS-stimulated B cells. 
Fig. S2 shows the distances from the follicle edge of LPS and nonactivated 
B cells. Fig. S3 shows by immunohistochemistry the location of the LPS-
stimulated B cells in the dark zone of a germinal center. Fig. S4 shows that 
the transfer of TLR4 ligand–exposed B cells enhanced a HEL-specifi  c anti-
body response. Fig. S5 shows the presence of LPS-stimulated and transferred 
B cells in germinal center present in the spleen of HEL-boosted mice. Video 
1 shows the results of intravital microscopy of LPS and nonactivated B cells 
in the iLN of an anesthetized mouse. Video 2 shows the tracking of TLR4-
stimulated B cells 48 h after transfer in the iLN. Video 3 shows the results of 
intravital microscopy of TLR4-stimulated B cells located in the light zone 
of an iLN germinal center. Video 4 shows TLR4-stimulated B cells in the 
dark zone of the germinal center. Video 5 compares TLR4-activated B cells 
to antigen-specifi  c B cells after transfer to a previously immunized recipient 
mouse visualized by intravital microscopy. Video 6 shows TLR4-stimulated 
B cells dividing in a LN germinal center. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20091982/DC1. 
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